Tags : Infectious Diseases

Sanofi Expands its 2018 Collaboration with Translate Bio to Develop

Shots: Translate Bio to receive $425M up front consisting $300M in cash and $125M as equity investment at $25.59/ share representing a 50% premium to the 20-day moving average share price prior to signing. The company will receive ~$1.9B as milestones, including $450M milestones under the 2018 agreement and expects $360M in next few years […]Read More

FDA and NIH Launch CURE ID Crowdsourcing App for Patients

Shots: The app is an internet-based repository which allows providers to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs via website, a smartphone and other mobile devices The CURE ID app enables the crowdsourcing of medical information from HCPs to guide potentially life-saving interventions and facilitate the development of […]Read More